Page last updated: 2024-09-04

bazedoxifene and Endometrial Neoplasms

bazedoxifene has been researched along with Endometrial Neoplasms in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	4 (66.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Beachler, DC; Dai, D; Daniels, K; Fournakis, N; Frajzyngier, V; Garg, RK; Governor, S; Hoffman, SR; Lanes, S; Mcmahill-Walraven, CN; Seals, RM; Shen, R; Shuminski, P; Wang, FT; Zhou, X; Ziyadeh, NJ	1
Chines, AA; de Villiers, TJ; Hines, T; Levine, AB; Mirkin, S; Nardone, Fde C; Palacios, S; Williams, R	1
Choe, GH; Flannery, CA; Fleming, AG; Naqvi, H; Sharma, A; Taylor, HS; Zhang, M	1
Bachmann, G; Pickar, JH; Speroff, L; Yeh, IT	1
Hadji, P	1
Calaf Alsina, J; Coronado Martín, PJ	1

Reviews

2 review(s) available for bazedoxifene and Endometrial Neoplasms

Article	Year
The evolution of selective estrogen receptor modulators in osteoporosis therapy. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Endometrial Neoplasms; Female; Fractures, Bone; Hot Flashes; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spinal Fractures; Tetrahydronaphthalenes	2012
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action]. Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism	2013

Article

Year

The evolution of selective estrogen receptor modulators in osteoporosis therapy.

Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:6

Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Endometrial Neoplasms; Female; Fractures, Bone; Hot Flashes; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spinal Fractures; Tetrahydronaphthalenes

2012

[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].

Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism

2013

Trials

2 trial(s) available for bazedoxifene and Endometrial Neoplasms

Article	Year
Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study. Maturitas, 2013, Volume: 76, Issue:1 Topics: Aged; Bone Density Conservation Agents; Carcinoma, Ovarian Epithelial; Double-Blind Method; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Incidence; Indoles; Middle Aged; Neoplasms, Glandular and Epithelial; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Postmenopause; Selective Estrogen Receptor Modulators; Spinal Fractures; Ultrasonography; Vaginitis	2013
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy. Fertility and sterility, 2009, Volume: 92, Issue:3 Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Outpatients; Postmenopause; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Treatment Outcome	2009

Article

Year

Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study.

Maturitas, 2013, Volume: 76, Issue:1

Topics: Aged; Bone Density Conservation Agents; Carcinoma, Ovarian Epithelial; Double-Blind Method; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Incidence; Indoles; Middle Aged; Neoplasms, Glandular and Epithelial; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Postmenopause; Selective Estrogen Receptor Modulators; Spinal Fractures; Ultrasonography; Vaginitis

2013

Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.

Fertility and sterility, 2009, Volume: 92, Issue:3

Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Outpatients; Postmenopause; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Treatment Outcome

2009

Other Studies

2 other study(ies) available for bazedoxifene and Endometrial Neoplasms

Article	Year
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study. Menopause (New York, N.Y.), 2023, 08-01, Volume: 30, Issue:8 Topics: Breast Neoplasms; Endometrial Hyperplasia; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Incidence; Selective Estrogen Receptor Modulators; United States	2023
Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium. Endocrinology, 2016, Volume: 157, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Animals; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Endometrioid; Case-Control Studies; Cells, Cultured; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fibroblast Growth Factors; Gene Expression Profiling; Humans; Indoles; Mice; Middle Aged; Selective Estrogen Receptor Modulators	2016

Article

Year

Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study.

Menopause (New York, N.Y.), 2023, 08-01, Volume: 30, Issue:8

Topics: Breast Neoplasms; Endometrial Hyperplasia; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Incidence; Selective Estrogen Receptor Modulators; United States

2023

Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.

Endocrinology, 2016, Volume: 157, Issue:10

Topics: Adult; Aged; Aged, 80 and over; Animals; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Endometrioid; Case-Control Studies; Cells, Cultured; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fibroblast Growth Factors; Gene Expression Profiling; Humans; Indoles; Mice; Middle Aged; Selective Estrogen Receptor Modulators

2016